MedTrace Logo

Antibiotic Study for Dental Implants

NCT00662532 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2011-12-12

Study results available
· View outcomes & findings →

Summary

This study is for people at least 21 years old who have signs of problems, like swollen gums and shrinking bones, by dental implants.

Conditions

  • Periodontitis

Interventions

DRUG

Minocycline HCl

1mg microspheres for professional subgingival administration into periodontal pockets two times throughout the duration of the trial

Sponsors & Collaborators

  • OraPharma

    lead INDUSTRY

Principal Investigators

  • Michael Lynch, DMD, PhD · OraPharma

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00662532 on ClinicalTrials.gov